Logo image of 8TI.DE

STELLANTIS NV (8TI.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:8TI - NL00150001Q9 - Common Stock

9.399 EUR
-0.05 (-0.53%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to 8TI. 8TI was compared to 32 industry peers in the Automobiles industry. 8TI has a bad profitability rating. Also its financial health evaluation is rather negative. 8TI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

8TI had negative earnings in the past year.
In the past year 8TI has reported a negative cash flow from operations.
8TI had positive earnings in each of the past 5 years.
8TI had a positive operating cash flow in each of the past 5 years.
8TI.DE Yearly Net Income VS EBIT VS OCF VS FCF8TI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

With a Return On Assets value of -1.19%, 8TI is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
8TI's Return On Equity of -3.27% is on the low side compared to the rest of the industry. 8TI is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
8TI.DE Yearly ROA, ROE, ROIC8TI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

In the last couple of years the Profit Margin of 8TI has declined.
In the last couple of years the Operating Margin of 8TI has declined.
Looking at the Gross Margin, with a value of 7.74%, 8TI is doing worse than 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of 8TI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for 8TI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-29.43%
OM growth 5Y-7.44%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
8TI.DE Yearly Profit, Operating, Gross Margins8TI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.
8TI has less shares outstanding than it did 1 year ago.
8TI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 8TI has a worse debt to assets ratio.
8TI.DE Yearly Shares Outstanding8TI.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
8TI.DE Yearly Total Debt VS Total Assets8TI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that 8TI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of 8TI (1.34) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.38 indicates that 8TI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, 8TI belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACCN/A
WACC7.04%
8TI.DE Yearly LT Debt VS Equity VS FCF8TI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

8TI has a Current Ratio of 1.06. This is a normal value and indicates that 8TI is financially healthy and should not expect problems in meeting its short term obligations.
8TI has a Current ratio of 1.06. This is in the lower half of the industry: 8TI underperforms 65.63% of its industry peers.
8TI has a Quick Ratio of 1.06. This is a bad value and indicates that 8TI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 8TI (0.77) is worse than 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
8TI.DE Yearly Current Assets VS Current Liabilites8TI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

8TI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.87%.
The earnings per share for 8TI have been decreasing by -15.26% on average. This is quite bad
8TI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.07%.
Measured over the past years, 8TI shows a small growth in Revenue. The Revenue has been growing by 7.72% on average per year.
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

The Earnings Per Share is expected to grow by 5.33% on average over the next years.
Based on estimates for the next years, 8TI will show a small growth in Revenue. The Revenue will grow by 3.49% on average per year.
EPS Next Y-101.49%
EPS Next 2Y-19.34%
EPS Next 3Y-2.49%
EPS Next 5Y5.33%
Revenue Next Year-2.46%
Revenue Next 2Y1.36%
Revenue Next 3Y2.09%
Revenue Next 5Y3.49%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
8TI.DE Yearly Revenue VS Estimates8TI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
8TI.DE Yearly EPS VS Estimates8TI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 8TI. In the last year negative earnings were reported.
8TI is valuated cheaply with a Price/Forward Earnings ratio of 6.35.
Based on the Price/Forward Earnings ratio, 8TI is valued cheaper than 81.25% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 8TI to the average of the S&P500 Index (24.03), we can say 8TI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.35
8TI.DE Price Earnings VS Forward Price Earnings8TI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 8TI.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.64
8TI.DE Per share data8TI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

A cheap valuation may be justified as 8TI's earnings are expected to decrease with -2.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.34%
EPS Next 3Y-2.49%

0

5. Dividend

5.1 Amount

No dividends for 8TI!.
Industry RankSector Rank
Dividend Yield 0%

STELLANTIS NV

FRA:8TI (12/23/2025, 7:00:00 PM)

9.399

-0.05 (-0.53%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners45.77%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap27.22B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts68.33
Price Target9.82 (4.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.34
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.32%
PT rev (3m)5.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-122.32%
EPS NY rev (3m)-104.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.35
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 1.17
EV/EBITDA 8.64
EPS(TTM)-0.83
EYN/A
EPS(NY)1.48
Fwd EY15.75%
FCF(TTM)-4.68
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.46
BVpS25.25
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.87%
ROCE(5y)12.83%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-29.43%
OM growth 5Y-7.44%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 7.15
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.34
F-Score1
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-101.49%
EPS Next 2Y-19.34%
EPS Next 3Y-2.49%
EPS Next 5Y5.33%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.46%
Revenue Next 2Y1.36%
Revenue Next 3Y2.09%
Revenue Next 5Y3.49%
EBIT growth 1Y-119.39%
EBIT growth 3Y-28.27%
EBIT growth 5Y-0.3%
EBIT Next Year17.24%
EBIT Next 3Y26.47%
EBIT Next 5Y20.5%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / 8TI.DE FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to 8TI.DE.


Can you provide the valuation status for STELLANTIS NV?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (8TI.DE). This can be considered as Overvalued.


How profitable is STELLANTIS NV (8TI.DE) stock?

STELLANTIS NV (8TI.DE) has a profitability rating of 2 / 10.


How financially healthy is STELLANTIS NV?

The financial health rating of STELLANTIS NV (8TI.DE) is 2 / 10.


Is the dividend of STELLANTIS NV sustainable?

The dividend rating of STELLANTIS NV (8TI.DE) is 0 / 10 and the dividend payout ratio is -81.93%.